NCI-2019-08392

A PHASE 1 STUDY OF ZN-c3 AS A SINGLE AGENT IN SUBJECTS WITH SOLID TUMORS

This study is testing a new medicine called ZN-c3 to see if it's safe for people with solid tumors. They want to see how well the medicine works on its own and if it can help treat cancer.

For more information about the trial, click the link below:

https://clinicaltrials.gov/ct2/show/NCT04158336

Clinical Trial Site: Sinai

To see all available clinical trials click here.